Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

In this cross-sectional analysis, researchers aimed to characterize the NIH trials affected by grant terminations under the Trump administration.

Cumulative probability of high-grade dysplasia, pancreatic ductal adenocarcinoma 26 percent at 10 years in high-risk individuals with MPD dilation ...

Funding accounted for 34.5 percent of total financial assistance requested in campaigns initiated between Jan. 1, 2021, and Feb. 28, 2023.

The phase 2 ChonDRAgon study compared ozekibart to placebo in patients with metastatic or unresectable conventional chondrosarcoma who been diagnosed with radiographic progression.

In this study, researchers examined associations between multiple primary cancer incidence and county-level smoking prevalence.

Researchers investigated the potential association between early-onset conventional adenomas, which are precursors to CRC, and serrated lesions, and higher intake of ultraprocessed foods.

This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...

Future research should focus on implementation studies and effectiveness in clinical settings and explore the applicability of TG-iConquerFear across different cancer types,” study researchers noted.

Barbara Burtness, MD highlights key news in head and neck cancer from ESMO 2025, including CAMORAL, ASPEN-03 & -04, OrigAMI-4 & -05 results.

A collaborative quality improvement initiative involving ACS-accredited radiotherapy programs sought to improve no show rates in patients with cancer.

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...